跳转至内容
Merck
搜索范围
文件类型

202-799-3

应用筛选条件
关键词:'202-799-3'
显示 1-9 #N/A 9 条结果 关于 "202-799-3" 范围 技术文档
Product Information Sheet - 11333151001
of the product. Product Pack size Cat. No. BM-Cyclin 37.5 mg (for 2× 2.5 l medium) 10 799 050 001 Geneticin (G 418) 1 g 5 g, non-sterile 11 464 981 001 11 464 990 001
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
., Nutrition, 16, 916-923 (2000). 116. Pelleymounter, M.A., et al., J. Pharmacol. Exp. Ther., 293, 799-806 (2000). 117. Richard, D., et al., Eur. J. Pharmacol., 440, 189-197 (2002). 118. Radulovic, M. and
S&E Campaign Lab Tools - Tables for laboratory use
La 3 [Xe] 5d 16s2 58 140.12 799 3443 1.08 Ce 3, 4 [Xe] 4f 15d16s 2 59 140.91 931 3520 1.07 Pr 3, 4 [Xe] 4f 36s2 60 144.24
Research Focus - Volume 2, 2013
); 30 µL Alzheimer’s Disease I - Tauopathy Investigator Antibody Mini-Pack (Qty: 3 vial/pk, Catalogue No. 15-202) • AB9560SP Anti-WWOX; 30 µg • AB9668SP Anti-Tau phospho Threonine 231; 30 µL
Calbiochem Biologics 32.2
et al. 2001. Proc. Natl. Acad. Sci. USA 98, 4640. Saltiel, A.R., and Kahn, C.R. 2001. Nature 414, 799. Contreres, J.O., et al. 1998. J. Biol. Chem. 273, 22007. White, M.F., and Yenush, L. 1998. Curr. Top
XP725 Worksheet for Lot Number 071M4826
KCNK9 K0514 792 5 1 3 8 KCNK9 K0514 793 5 1 4 1 Kaiso K4263 794 5 1 4 2 Kaiso K4263 795 5 1 4 3 KIF17 K3638 796 5 1 4 4 KIF17 K3638 797 5 1 4 5 KIF3A K3513 798 5 1
Halal Certificate
98%, FCC, FG W261408 B13921 HC-24SI3C66 798. LAURIC ACID, NATURAL W261416 C36285 HC-24SIGW27 799. LAURIC ALDEHYDE 95%, FCC, FG W261505 B86829 HC-24SI3678 800. LAURIC ALDEHYDE NATURAL, 95%, FG W261513
Halal Certificate
98%, FCC, FG W261408 B13921 HC-22SI1W64 798. LAURIC ACID, NATURAL W261416 C36285 HC-22SIFB25 799. LAURIC ALDEHYDE 95%, FCC, FG W261505 B86829 HC-22SIIE76 800. LAURIC ALDEHYDE NATURAL, 95%, FG W261513
Inhibitor Sourcebook 3rd Edition
...199 HNMPA-(AM)3 .............................................................................. 71 Hsp25 Kinase Inhibitor...................................................... 30, 202 HSP90 Inhibitor